Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › interferon beta-1a

interferon beta-1a

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of interferon beta-1a

13 trials tracked of interferon beta-1a: 9 in phase 3 or 4 and 1 with published results. The most-cited published study has 306 citations.

13Trials tracked
9Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 1 Phase 3 8 Phase 2 2 Phase 1 2
  1. Phase 3 Adaptive COVID-19 Treatment Trial 3 (ACTT-3) Completed · 306 cited
  2. Phase 4 Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis Patients Completed
  3. Phase 3 Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis Completed
  4. Phase 3 Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two Completed
  5. Phase 3 A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis Completed
  6. Phase 3 A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis Completed
Show 7 more trials
  1. Phase 3 Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis Completed
  2. Phase 3 Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One Completed
  3. Phase 3 Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) Completed
  4. Phase 2 A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease Completed
  5. Phase 2 A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis Completed
  6. Phase 1 Pharmacodynamic Biomarkers to Support Biosimilar Development: Interferon Beta-1A Products Completed
  7. Phase 1 Pharmacokinetics and Pharmacodynamics Study of BCD-033 Compared to Rebif® in Healthy Volunteers Completed

Showing the 13 most-cited and recently-updated of 13 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.